AG

Adam Goulburn

Founder Dimension

New York, New York

Investor
VC
Founder

Invests in

Stages:

Series B
Series A
Seed

Sectors:

Data Services
BioTech
Health & Hospital Services
Consumer Health
Health IT
Digital Health
New York City

Locations:

New York, New York
  • Min Investment:

    $1,000,000.00
  • Max Investment:

    $3,000,000.00
  • Target Investment:

    $2,000,000.00

Skills

Venture Capital
Lifesciences
Entrepreneurship
Regenerative Medicine
Biotechnology
Commercialization
Start-ups
Digital Health

Education

  • MU

    PhD

    Monash University

    (2006 - 2010)

  • U

    Bachelor of Commerce / Bachelor of Science

    UNSW

    (2001 - 2005)

Lists including Adam

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Kaleidoscope

Seed

Total Funding: $22M

Rivet

Series A

Total Funding: $33M

Plexium

Series A

Total Funding: $140M

Gandeeva Therapeutics

Series A

Total Funding: $40M

Eikon Therapeutics

Seed

Total Funding: $670M

Science 37

Series Unknown

Total Funding: $240M

AllStripes

Seed

Total Funding: $67M

Cajal Neuroscience

Seed

Total Funding: $96M

Adimab

Series Unknown

Total Funding: $41M

Performance Drone Works

Seed

Total Funding:

Work Experience

D
Dimension

2022

  • Co-Founder

    2022

LC
Lux Capital

2011 - 2022

  • Venture Partner

    2022 - 2022

  • Partner

    2015 - 2022

  • Principal

    2014 - 2015

  • Senior Associate

    2012 - 2014

  • Associate

    2011 - 2012

VNV Bio (now Aera Therapeutics)

2018 - 2021

  • Founding CEO

    2018 - 2021

K
Kallyope

2014 - 2015

  • Founding CEO

    2014 - 2015

WC
Weill Cornell Medical College

2010 - 2011

  • Post-Doctoral Associate

    2010 - 2011

    Fellow of Neuroscience

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.